Plasma Lipophilic Index and Risk of Coronary Heart Disease in Postmenopausal Women

被引:0
作者
Liu, Qing
Lichtenstein, Alice H.
Matthan, Nirupa R.
Liu, Simin
Allison, Matthew A.
Howard, Barbara V.
Martin, Lisa W.
Valdiviezo, Carolina
Manson, Joann E.
Eaton, Charles B.
机构
关键词
Coronary heart disease; Lipids;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
MP38
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Impact of body mass index on coronary heart disease risk factors in men and women - The Framingham Offspring Study
    LamonFava, S
    Wilson, PWF
    Schaefer, EJ
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (12) : 1509 - 1515
  • [42] Plasma Biomarker Profiles for Premature and Nonpremature Coronary Heart Disease in Women
    Dugani, Sagar B.
    Moorthy, M. Vinayaga
    Demler, Olga, V
    Li, Chunying
    Ridker, Paul M.
    Glynn, Robert J.
    Mora, Samia
    CLINICAL CHEMISTRY, 2024, 70 (05) : 768 - 779
  • [43] HEMOSTATIC, METABOLIC, AND ANDROGENIC RISK-FACTORS FOR CORONARY HEART-DISEASE IN PHYSICALLY ACTIVE AND LESS ACTIVE POSTMENOPAUSAL WOMEN
    STEVENSON, ET
    DAVY, KP
    SEALS, DR
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (05) : 669 - 677
  • [44] Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease
    Russo, G. T.
    Giandalia, A.
    Romeo, E. L.
    Marotta, M.
    Alibrandi, A.
    De Francesco, C.
    Horvath, K. V.
    Asztalos, B.
    Cucinotta, D.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2014, 37 (03) : 261 - 268
  • [45] Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease
    G. T. Russo
    A. Giandalia
    E. L. Romeo
    M. Marotta
    A. Alibrandi
    C. De Francesco
    K. V. Horvath
    B. Asztalos
    D. Cucinotta
    Journal of Endocrinological Investigation, 2014, 37 : 261 - 268
  • [46] Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu, Nigeria
    Nwagha, U., I
    Ikekpeazu, E. J.
    Ejezie, F. E.
    Neboh, E. E.
    Maduka, I. C.
    AFRICAN HEALTH SCIENCES, 2010, 10 (03) : 248 - 252
  • [47] Beta-blocker use is associated with fragility fractures in postmenopausal women with coronary heart disease
    Manuel Sosa
    Pedro Saavedra
    María Jesús Gómez de Tejada
    José Mosquera
    Ramón Pérez-Cano
    José Manuel Olmos
    Manuel Muñoz-Torres
    María José Amérigo
    María Jesús Moro
    Manuel Díaz-Curiel
    Javier Alegre
    Jorge Malouf
    Javier del Pino
    Xavier Nogués
    Antonio Torrijos
    Aging Clinical and Experimental Research, 2011, 23 (2) : 112 - 117
  • [48] Beta-blocker use is associated with fragility fractures in postmenopausal women with coronary heart disease
    Manuel Sosa
    Pedro Saavedra
    María Jesús Gómez de Tejada
    José Mosquera
    Ramón Pérez-Cano
    José Manuel Olmos
    Manuel Muñoz-Torres
    María José Amérigo
    María Jesús Moro
    Manuel Díaz-Curiel
    Javier Alegre
    Jorge Malouf
    Javier del Pino
    Xavier Nogués
    Antonio Torrijos
    Aging Clinical and Experimental Research, 2011, 23 : 112 - 117
  • [49] Beta-blocker use is associated with fragility fractures in postmenopausal women with coronary heart disease
    Sosa, Manuel
    Saavedra, Pedro
    Jesus Gomez de Tejada, Maria
    Mosquera, Jose
    Perez-Cano, Ramon
    Manuel Olmos, Jose
    Munoz-Torres, Manuel
    Jose Amerigo, Maria
    Jesus Moro, Maria
    Diaz-Curiel, Manuel
    Alegre, Javier
    Malouf, Jorge
    del Pino, Javier
    Nogues, Xavier
    Torrijos, Antonio
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2011, 23 (02) : 112 - 117
  • [50] Emerging Selective Estrogen Receptor ModulatorsSpecial Focus on Effects on Coronary Heart Disease in Postmenopausal Women
    Tatjana Elène Vogelvang
    Marius Jan van der Mooren
    Velja Mijatovic
    Peter Kenemans
    Drugs, 2006, 66 : 191 - 221